Director/PDMR Shareholding

RNS Number : 9024Y

GlaxoSmithKline PLC

04 January 2011

 



Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.

On 31 December 2010, the Company's Non-Executive Directors were provisionally allocated awards over Ordinary shares at a price of £12.55 per Ordinary share and $39.18 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 October 2010 to 31 December 2010:

Non Executive Director	Ordinary Shares	American Depository Shares (ADSs)
Sir Christopher Gent	2,689.24
Prof. Sir Roy Anderson	672.31
Dr Stephanie Burns		390.65
Mr Lawrence Culp		781.30
Sir Crispin Davis	2,490.04
Sir Deryck Maughan		781.30
Mr James Murdoch	2,091.63
Dr Daniel Podolsky		820.36
Mr Tom de Swaan	921.32
Sir Robert Wilson	672.31

The Company and the Non-Executive Directors were informed of these allocations on 4 January 2011.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

4 January 2011

 

END

 

 

RDSQZLFBFFFLBBL